Feedback / Questions
TG4050 - Transgene, NEC Corp
https://www.globenewswire.com/news-release/2025/06/19/3102009/0/en/Transgene-Completes-Initial-Patient-Screening-in-Phase-II-Part-of-TG4050-Trial-in-Operable-Head-and-Neck-Cancer.html
Jun 19, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next